• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增生型糖尿病性视网膜病变的代谢指纹:一种基于 1H-NMR 的代谢组学方法,使用玻璃体。

Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.

机构信息

Laboratory of Experimental Cardiology, Heart Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

出版信息

Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4416-21. doi: 10.1167/iovs.10-5348. Epub 2010 Apr 7.

DOI:10.1167/iovs.10-5348
PMID:20375324
Abstract

PURPOSE

To explore the metabolic profile of vitreous fluid of patients with proliferative diabetic retinopathy (PDR) using 1H-NMR-based metabonomic analysis.

METHODS

1H-NMR spectra were acquired from vitreous samples obtained during vitrectomy from 22 patients with type 1 diabetes with PDR and from 22 nondiabetic patients with macular hole (control group). Data analysis included a principal component analysis and partial least squares discriminant analysis (PLS-DA). In addition, 1H-(1)H and 1H-(13)C HMQC correlation spectra were acquired for the identification of metabolites. Furthermore, the main metabolites accounting for the differences in metabolic profile were assessed by current biochemical methods.

RESULTS

Lactate was the most abundant metabolite, and it was present at higher levels in samples from PDR patients than from nondiabetic patients (P=0.02). Glucose was significantly higher in samples from PDR patients than nondiabetic patients (P=0.03). After removing the lactate peak at 1.35 ppm and with the use of PLS-DA, a model was obtained that was able to correctly classify 19 of 22 patients with PDR and 18 of 22 controls, resulting in a sensitivity of 86% and a specificity of 81%. The main metabolites involved in this specific pattern recognition were galactitol and ascorbic acid (AA); levels of both were significantly lower in PDR patients.

CONCLUSIONS

1H-NMR-based metabonomic analysis of vitreous fluid permits the obtainment of a metabolic signature of PDR. Apart from the higher abundance of lactate and glucose, significant deficits of galactitol and AA are the main metabolic fingerprints of vitreous fluid from PDR patients.

摘要

目的

应用基于 1H-NMR 的代谢组学分析方法,探讨增生性糖尿病视网膜病变(PDR)患者玻璃体代谢特征。

方法

对 22 例 1 型糖尿病 PDR 患者和 22 例无糖尿病性黄斑裂孔(对照组)患者行玻璃体切割术时获取的玻璃体样本进行 1H-NMR 谱检测。数据分析包括主成分分析和偏最小二乘判别分析(PLS-DA)。另外,还采集了 1H-1H 和 1H-13C HMQC 相关谱以鉴定代谢物。此外,还采用当前生化方法评估导致代谢谱差异的主要代谢物。

结果

乳酸是最丰富的代谢物,PDR 患者样本中含量高于非糖尿病患者(P=0.02)。葡萄糖在 PDR 患者样本中明显高于非糖尿病患者(P=0.03)。在去除 1.35 ppm 处的乳酸峰并采用 PLS-DA 后,得到了一个能够正确分类 22 例 PDR 患者中的 19 例和 22 例对照组中的 18 例的模型,敏感性为 86%,特异性为 81%。参与这种特定模式识别的主要代谢物是半乳糖醇和抗坏血酸(AA);PDR 患者中这两种物质的水平明显降低。

结论

基于 1H-NMR 的玻璃体代谢组学分析可获得 PDR 的代谢特征。除了乳酸和葡萄糖含量较高外,半乳糖醇和 AA 的显著缺乏是 PDR 患者玻璃体代谢的主要特征。

相似文献

1
Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.增生型糖尿病性视网膜病变的代谢指纹:一种基于 1H-NMR 的代谢组学方法,使用玻璃体。
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4416-21. doi: 10.1167/iovs.10-5348. Epub 2010 Apr 7.
2
Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体液和视网膜前膜中的心房利钠肽。
Mol Vis. 2004 Jul 15;10:450-7.
3
Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体液和视网膜前膜中的免疫反应性内皮素-1
Retina. 2007 Feb;27(2):222-35. doi: 10.1097/01.iae.0000231376.76601.40.
4
Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体内血管生成素2和血管内皮生长因子的水平
Am J Ophthalmol. 2005 Mar;139(3):476-81. doi: 10.1016/j.ajo.2004.10.004.
5
Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体内血管内皮生长因子和缺氧诱导因子1α
Am J Ophthalmol. 2009 Dec;148(6):883-9. doi: 10.1016/j.ajo.2009.07.007. Epub 2009 Oct 17.
6
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.增殖性糖尿病视网膜病变和增殖性玻璃体视网膜病变中的趋化因子
Eur Cytokine Netw. 2006 Sep;17(3):155-65.
7
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.玻璃体切除术后增殖性糖尿病视网膜病变患者玻璃体腔内血管内皮生长因子持续分泌
Ophthalmology. 2004 Oct;111(10):1880-4. doi: 10.1016/j.ophtha.2004.03.035.
8
Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中玻璃体内活性氧的水平
Ophthalmology. 2008 Apr;115(4):734-737.e1. doi: 10.1016/j.ophtha.2007.05.041. Epub 2008 Jan 4.
9
1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.基于1H核磁共振的代谢组学及模式识别分析用于口腔鳞状细胞癌的检测
Clin Chim Acta. 2009 Mar;401(1-2):8-13. doi: 10.1016/j.cca.2008.10.030. Epub 2008 Nov 9.
10
Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者玻璃体内白细胞介素-8水平
Am J Ophthalmol. 2007 Jan;143(1):175-6. doi: 10.1016/j.ajo.2006.07.032. Epub 2006 Sep 1.

引用本文的文献

1
Metabolic Deficiencies in the Vitreous of Diabetic Retinopathy: Exploring the Potential of Dietary Supplementation to Address Key Metabolite Imbalances.糖尿病视网膜病变玻璃体中的代谢缺陷:探索膳食补充剂解决关键代谢物失衡问题的潜力。
Clin Ophthalmol. 2025 Aug 27;19:2997-3007. doi: 10.2147/OPTH.S531638. eCollection 2025.
2
New insights of potential biomarkers in diabetic retinopathy: integrated multi-omic analyses.糖尿病视网膜病变潜在生物标志物的新见解:综合多组学分析
Front Endocrinol (Lausanne). 2025 Jul 1;16:1595207. doi: 10.3389/fendo.2025.1595207. eCollection 2025.
3
Metabolomic biomarkers in vitreous humor: unveiling the molecular landscape of diabetic retinopathy progression.
玻璃体液中的代谢组学生物标志物:揭示糖尿病视网膜病变进展的分子图景。
Int J Retina Vitreous. 2025 May 22;11(1):58. doi: 10.1186/s40942-025-00682-5.
4
Histone Modifications: Potential Therapeutic Targets for Diabetic Retinopathy.组蛋白修饰:糖尿病视网膜病变的潜在治疗靶点
Biomolecules. 2025 Apr 12;15(4):575. doi: 10.3390/biom15040575.
5
Identification of unique biomarkers for proliferative diabetic retinopathy with tractional retinal detachment by proteomics profiling of vitreous humor.通过对玻璃体液进行蛋白质组学分析鉴定增殖性糖尿病视网膜病变合并牵拉性视网膜脱离的独特生物标志物
Sci Rep. 2025 Apr 18;15(1):13456. doi: 10.1038/s41598-025-98327-y.
6
Effect of the Mediterranean Diet (MeDi) on the Progression of Retinal Disease: A Narrative Review.地中海饮食(MeDi)对视网膜疾病进展的影响:叙述性综述。
Nutrients. 2024 Sep 19;16(18):3169. doi: 10.3390/nu16183169.
7
Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia.常见多因素眼病的代谢组学研究:年龄相关性黄斑变性、青光眼、糖尿病视网膜病变和近视生物标志物发现的综述
Front Mol Biosci. 2024 Aug 13;11:1403844. doi: 10.3389/fmolb.2024.1403844. eCollection 2024.
8
Ferrous ascorbate as a potential biomarker for diabetic retinopathy: a vitreous humour metabolomics study.富马酸亚铁作为糖尿病性视网膜病变的潜在生物标志物:玻璃体液代谢组学研究。
BMC Ophthalmol. 2024 Jun 24;24(1):270. doi: 10.1186/s12886-024-03530-6.
9
Causal association of circulating metabolites with diabetic retinopathy: a bidirectional Mendelian randomization analysis.循环代谢物与糖尿病视网膜病变的因果关系:双向孟德尔随机化分析。
Front Endocrinol (Lausanne). 2024 May 10;15:1359502. doi: 10.3389/fendo.2024.1359502. eCollection 2024.
10
WNT-inhibitory factor 1-mediated glycolysis protects photoreceptor cells in diabetic retinopathy.WNT 抑制因子 1 介导的糖酵解在糖尿病性视网膜病变中保护光感受器细胞。
J Transl Med. 2024 Mar 6;22(1):245. doi: 10.1186/s12967-024-05046-5.